Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many people have entered the Improving Access to Psychological Therapies Programme in (a) England, (b) the North West and (c) East Lancashire in each of the last three years.
Answered by Baroness Blackwood of North Oxford
The table provides figures for the number of referrals entering Improving Access to Psychological Therapies (IAPT) treatment by clinical commissioning group (CCG), England, 2012-13, 2013-14, and 2014-15.
England |
|
|
|
| |
| Number of referrals entering treatment | ||||
CCG Code | CCG Name | 2012-13 | 2013-14 | 2014-15 | |
| All England | 434,247 | 709,117 | 815,665 | |
00C | NHS Darlington CCG | 1,015 | 1,360 | 1,310 | |
00D | NHS Durham Dales, Easington and Sedgefield CCG | 2,834 | 3,470 | 3,420 | |
00F | NHS Gateshead CCG | 3,075 | 3,735 | 4,200 | |
00G | NHS Newcastle North and East CCG | 1,370 | 3,525 | 3,400 | |
00H | NHS Newcastle West CCG | 1,122 | 2,610 | 2,485 | |
00J | NHS North Durham CCG | 2,829 | 3,190 | 3,285 | |
00K | NHS Hartlepool and Stockton-On-Tees CCG | 2,837 | 7,050 | 5,605 | |
00L | NHS Northumberland CCG | 4,541 | 6,800 | 6,410 | |
00M | NHS South Tees CCG | 3,339 | 5,820 | 4,650 | |
00N | NHS South Tyneside CCG | 2,060 | 3,050 | 3,655 | |
00P | NHS Sunderland CCG | 1,312 | 5,220 | 5,615 | |
00Q | NHS Blackburn with Darwen CCG | 1,098 | 1,280 | 3,305 | |
00R | NHS Blackpool CCG | 268 | 1,730 | 2,340 | |
00T | NHS Bolton CCG | 11 | 4,760 | 5,690 | |
00V | NHS Bury CCG | 1,710 | 3,070 | 4,220 | |
00W | NHS Central Manchester CCG | 1,269 | 1,750 | 1,960 | |
00X | NHS Chorley and South Ribble CCG | 1,816 | 2,225 | 3,200 | |
00Y | NHS Oldham CCG | 564 | 2,330 | 3,760 | |
01A | NHS East Lancashire CCG | 3,420 | 3,495 | 6,980 | |
01C | NHS Eastern Cheshire CCG | 1,093 | 1,985 | 1,965 | |
01D | NHS Heywood, Middleton and Rochdale CCG | 1,156 | 3,280 | 4,425 | |
01E | NHS Greater Preston CCG | 3,096 | 2,260 | 3,960 | |
01F | NHS Halton CCG | 572 | 750 | 1,455 | |
01G | NHS Salford CCG | 1,767 | 5,255 | 6,930 | |
01H | NHS Cumbria CCG | 8,441 | 8,690 | 7,260 | |
01J | NHS Knowsley CCG | 861 | 1,915 | 2,575 | |
01K | NHS Lancashire North CCG | 1,511 | 1,505 | 3,030 | |
01M | NHS North Manchester CCG | 786 | 1,465 | 1,720 | |
01N | NHS South Manchester CCG | 1,392 | 1,660 | 1,825 | |
01R | NHS South Cheshire CCG | 1,158 | 2,085 | 1,920 | |
01T | NHS South Sefton CCG | 1,630 | 2,170 | 3,185 | |
01V | NHS Southport And Formby CCG | 1,130 | 1,490 | 2,100 | |
01W | NHS Stockport CCG | 1,274 | 2,330 | 5,290 | |
01X | NHS St Helens CCG | 990 | 1,070 | 1,885 | |
01Y | NHS Tameside and Glossop CCG | 970 | 2,045 | 5,505 | |
02A | NHS Trafford CCG | 3,182 | 3,840 | 4,405 | |
02D | NHS Vale Royal CCG | 755 | 1,375 | 1,255 | |
02E | NHS Warrington CCG | 694 | 3,250 | 3,265 | |
02F | NHS West Cheshire CCG | 4,803 | 4,350 | 4,515 | |
02G | NHS West Lancashire CCG | 1,454 | 1,635 | 2,155 | |
02H | NHS Wigan Borough CCG | 3,536 | 6,020 | 3,990 | |
02M | NHS Fylde and Wyre CCG | 1,534 | 1,510 | 2,550 | |
12F | NHS Wirral CCG | 3,323 | 4,080 | 5,410 | |
99A | NHS Liverpool CCG | 6,684 | 8,115 | 9,420 | |
99C | NHS North Tyneside CCG | 0 | 5,015 | 3,810 | |
Data source: IAPT, Health and Social Care Information Centre (HSCIC)
Notes:
1. A referral is classified as having entered treatment if it has a first, attended treatment appointment in the year.
2. For 2012-13, referrals entering treatment is a subset of referrals received in the year, as this was the first year of the IAPT programme.
3. For 2014-15, CCG is the recorded commissioner, unless this was not recorded or not a CCG, in which case the CCG is derived from the patient’s general practitioner (GP) practice or postcode. For 2013-14 and 2012-13, CCG is based on GP Practice. Where CCG and GP Practice were not recorded and could not be assigned, the referral is categorised as 'Unknown'. A list of valid CCGs can be found on the HSCIC website at:
http://systems.hscic.gov.uk/data/ods/datadownloads/othernhs
4. For this response, we are defining North West and East Lancashire as those CCGs within the following NHS Health Authority regions: Q74 - NHS England North (Cumbria and North East), Q75 - NHS England North (Cheshire and Merseyside), Q83 - NHS England North (Greater Manchester), Q84 - NHS England North (Lancashire).
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department is taking to improve community-based eating disorder services in East Lancashire.
Answered by Baroness Blackwood of North Oxford
The provision of local health services is a matter for the local National Health Service.
The Lancashire Children and Young People’s Resilience, Emotional Wellbeing and Mental Health Transformation Plan 2015-2020 sets out plans for improvements to services, including eating disorder services. The Plan can be accessed using the following link:
http://www.blackburnwithdarwenccg.nhs.uk/health/child-health/camhs/
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much the NHS spent on Lyme disease laboratory tests in each of the last three years.
Answered by Jane Ellison
As services for the treatment of Lyme disease are commissioned locally information on the costs associated with laboratory testing and treatment of late stage Lyme disease is not collected centrally. Nor is information collected centrally on the average time to diagnose cases of Lyme disease.
The National Institute for Health and Care Excellence (NICE) is developing a clinical guideline on Lyme disease and reports progress on its website. NICE recently consulted on a draft scope for the guideline, and expects to publish final guidance in July 2018.
Public Health England and NHS Choices publish information on their websites to raise awareness of Lyme disease and encourage timely medical consultation because early diagnosis and treatment of Lyme disease is the best way of limiting complications from infection. Given the need to maintain public awareness these or similar mechanisms are expected to continue beyond 2018. Increased awareness is likely to encourage early consultation but no information on the time taken to seek medical advice is available.
There are no plans to set targets for diagnosis and treatment as most cases of Lyme disease are diagnosed empirically by general practitioners using their clinical judgement rather than relying on a laboratory test, thus treatment can start immediately. Diagnosis of patients with late or complicated Lyme disease can be difficult and the National Health Service will continue to provide care taking account of the existing evidence base.
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department is taking to ensure that new guidelines on the recognition and treatment of Lyme disease are made available by July 2018.
Answered by Jane Ellison
As services for the treatment of Lyme disease are commissioned locally information on the costs associated with laboratory testing and treatment of late stage Lyme disease is not collected centrally. Nor is information collected centrally on the average time to diagnose cases of Lyme disease.
The National Institute for Health and Care Excellence (NICE) is developing a clinical guideline on Lyme disease and reports progress on its website. NICE recently consulted on a draft scope for the guideline, and expects to publish final guidance in July 2018.
Public Health England and NHS Choices publish information on their websites to raise awareness of Lyme disease and encourage timely medical consultation because early diagnosis and treatment of Lyme disease is the best way of limiting complications from infection. Given the need to maintain public awareness these or similar mechanisms are expected to continue beyond 2018. Increased awareness is likely to encourage early consultation but no information on the time taken to seek medical advice is available.
There are no plans to set targets for diagnosis and treatment as most cases of Lyme disease are diagnosed empirically by general practitioners using their clinical judgement rather than relying on a laboratory test, thus treatment can start immediately. Diagnosis of patients with late or complicated Lyme disease can be difficult and the National Health Service will continue to provide care taking account of the existing evidence base.
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department is taking before the introduction of new guidelines on the recognition and treatment of Lyme disease expected by July 2018 to ensure that people with that disease are diagnosed quickly.
Answered by Jane Ellison
As services for the treatment of Lyme disease are commissioned locally information on the costs associated with laboratory testing and treatment of late stage Lyme disease is not collected centrally. Nor is information collected centrally on the average time to diagnose cases of Lyme disease.
The National Institute for Health and Care Excellence (NICE) is developing a clinical guideline on Lyme disease and reports progress on its website. NICE recently consulted on a draft scope for the guideline, and expects to publish final guidance in July 2018.
Public Health England and NHS Choices publish information on their websites to raise awareness of Lyme disease and encourage timely medical consultation because early diagnosis and treatment of Lyme disease is the best way of limiting complications from infection. Given the need to maintain public awareness these or similar mechanisms are expected to continue beyond 2018. Increased awareness is likely to encourage early consultation but no information on the time taken to seek medical advice is available.
There are no plans to set targets for diagnosis and treatment as most cases of Lyme disease are diagnosed empirically by general practitioners using their clinical judgement rather than relying on a laboratory test, thus treatment can start immediately. Diagnosis of patients with late or complicated Lyme disease can be difficult and the National Health Service will continue to provide care taking account of the existing evidence base.
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the average time taken is for the NHS to diagnose cases of Lyme disease.
Answered by Jane Ellison
As services for the treatment of Lyme disease are commissioned locally information on the costs associated with laboratory testing and treatment of late stage Lyme disease is not collected centrally. Nor is information collected centrally on the average time to diagnose cases of Lyme disease.
The National Institute for Health and Care Excellence (NICE) is developing a clinical guideline on Lyme disease and reports progress on its website. NICE recently consulted on a draft scope for the guideline, and expects to publish final guidance in July 2018.
Public Health England and NHS Choices publish information on their websites to raise awareness of Lyme disease and encourage timely medical consultation because early diagnosis and treatment of Lyme disease is the best way of limiting complications from infection. Given the need to maintain public awareness these or similar mechanisms are expected to continue beyond 2018. Increased awareness is likely to encourage early consultation but no information on the time taken to seek medical advice is available.
There are no plans to set targets for diagnosis and treatment as most cases of Lyme disease are diagnosed empirically by general practitioners using their clinical judgement rather than relying on a laboratory test, thus treatment can start immediately. Diagnosis of patients with late or complicated Lyme disease can be difficult and the National Health Service will continue to provide care taking account of the existing evidence base.
Asked by: Andrew Stephenson (Conservative - Pendle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what targets his Department has set to increase early diagnosis and treatment of Lyme disease.
Answered by Jane Ellison
As services for the treatment of Lyme disease are commissioned locally information on the costs associated with laboratory testing and treatment of late stage Lyme disease is not collected centrally. Nor is information collected centrally on the average time to diagnose cases of Lyme disease.
The National Institute for Health and Care Excellence (NICE) is developing a clinical guideline on Lyme disease and reports progress on its website. NICE recently consulted on a draft scope for the guideline, and expects to publish final guidance in July 2018.
Public Health England and NHS Choices publish information on their websites to raise awareness of Lyme disease and encourage timely medical consultation because early diagnosis and treatment of Lyme disease is the best way of limiting complications from infection. Given the need to maintain public awareness these or similar mechanisms are expected to continue beyond 2018. Increased awareness is likely to encourage early consultation but no information on the time taken to seek medical advice is available.
There are no plans to set targets for diagnosis and treatment as most cases of Lyme disease are diagnosed empirically by general practitioners using their clinical judgement rather than relying on a laboratory test, thus treatment can start immediately. Diagnosis of patients with late or complicated Lyme disease can be difficult and the National Health Service will continue to provide care taking account of the existing evidence base.